share_log

和鉑醫藥-B：截至二零二四年二月二十九日止之股份發行人的證券變動月報表

HBM HOLDINGS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 6 03:33
Summary by Moomoo AI
和鉑醫藥控股有限公司（和铂医药-B）於2024年3月6日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年2月29日的情況。報告顯示，公司的法定/註冊股本在本月內無變動，結存總額維持在500,000美元，對應20,000,000,000股普通股，每股面值0.000025美元。此外，公司的股份期權計劃亦無變動，本月底結存的股份期權數目為39,250,950，且無新股份因行使期權而發行。報告還提到，公司於2023年6月8日購回了1,750,000股普通股，但本月內普通股的增減總額為零。公司確認，所有證券的發行均已獲得董事會的正式授權，並符合相關法律規定。
和鉑醫藥控股有限公司（和铂医药-B）於2024年3月6日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年2月29日的情況。報告顯示，公司的法定/註冊股本在本月內無變動，結存總額維持在500,000美元，對應20,000,000,000股普通股，每股面值0.000025美元。此外，公司的股份期權計劃亦無變動，本月底結存的股份期權數目為39,250,950，且無新股份因行使期權而發行。報告還提到，公司於2023年6月8日購回了1,750,000股普通股，但本月內普通股的增減總額為零。公司確認，所有證券的發行均已獲得董事會的正式授權，並符合相關法律規定。
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 6, 2024, COVERING THE SITUATION AS OF FEBRUARY 29, 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with a total deposit of $500,000, corresponding to 20,000,000,000 shares of ordinary shares with a face value of $0.000025 per share. In addition, the Company's stock option plan remained unchanged, with 39,250,950 share options outstanding at the end of the month, and no new shares were issued as a result of the exercise of options. The report also noted that the company repurchased 1,750,000 shares of ordinary shares on June 8, 2023, but the total increase in ordinary shares during the month was zero. The Company confirms that all issues of securities have been formally authorized by the Board of Directors and comply with the relevant legal requirements.
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTHLY CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MARCH 6, 2024, COVERING THE SITUATION AS OF FEBRUARY 29, 2024. The report shows that the company's regulated/registered share capital remained unchanged during the month, with a total deposit of $500,000, corresponding to 20,000,000,000 shares of ordinary shares with a face value of $0.000025 per share. In addition, the Company's stock option plan remained unchanged, with 39,250,950 share options outstanding at the end of the month, and no new shares were issued as a result of the exercise of options. The report also noted that the company repurchased 1,750,000 shares of ordinary shares on June 8, 2023, but the total increase in ordinary shares during the month was zero. The Company confirms that all issues of securities have been formally authorized by the Board of Directors and comply with the relevant legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more